Characterisation of patients with a complete biochemical response to ursodeoxycholic acid

R. A. Jorgensen, E. R. Dickson, A. F. Hofmann, S. S. Rossi, Keith Lindor

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Ursodeoxycholic acid (UDCA) leads to biochemical and clinical improvement in many patients with primary biliary cirrhosis (PBC); although, the response is variable. This study compared UDCA treated patients with complete normalisation of biochemical functions to those without such improvement. Of the 65 patients receiving UDCA, 12 (19%) showed normalisation of liver biochemical functions at two years. The remaining 53 patients showed a less complete response. Mean (SD) alkaline phosphatase and total serum bilirubin values were significantly lower at entry in the patients whose liver biochemistry tests normalised (912 (732) U/l v 1417 (1021) U/l, p = 0.003, and 0.7 (12.1 (5.2) μmol/l v 38.9 (48.5) μmol/l, p = 0.0002, respectively), and percentage of UDCA in biliary bile acid was higher (56.3 (9.5)% v 38.3 (21.1)%, p = 0.03). Patients with biochemically and histologically less severe disease, and greater enrichment of biliary bile with UDCA, are more likely to respond favourably to the drug. The main objective of continued study will be to find out if normal liver biochemical functions can retard disease progression. The association of greater UDCA enrichment with complete biochemical responses suggests that higher doses of UDCA should be evaluated.

Original languageEnglish (US)
Pages (from-to)935-938
Number of pages4
JournalGut
Volume36
Issue number6
StatePublished - Jun 1995
Externally publishedYes

Fingerprint

Ursodeoxycholic Acid
Liver
Biliary Liver Cirrhosis
Bile Acids and Salts
Bilirubin
Bile
Biochemistry
Alkaline Phosphatase
Disease Progression
Serum
Pharmaceutical Preparations

Keywords

  • Primary biliary cirrhosis
  • Ursodeoxycholic acid

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Jorgensen, R. A., Dickson, E. R., Hofmann, A. F., Rossi, S. S., & Lindor, K. (1995). Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. Gut, 36(6), 935-938.

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. / Jorgensen, R. A.; Dickson, E. R.; Hofmann, A. F.; Rossi, S. S.; Lindor, Keith.

In: Gut, Vol. 36, No. 6, 06.1995, p. 935-938.

Research output: Contribution to journalArticle

Jorgensen, RA, Dickson, ER, Hofmann, AF, Rossi, SS & Lindor, K 1995, 'Characterisation of patients with a complete biochemical response to ursodeoxycholic acid', Gut, vol. 36, no. 6, pp. 935-938.
Jorgensen RA, Dickson ER, Hofmann AF, Rossi SS, Lindor K. Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. Gut. 1995 Jun;36(6):935-938.
Jorgensen, R. A. ; Dickson, E. R. ; Hofmann, A. F. ; Rossi, S. S. ; Lindor, Keith. / Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. In: Gut. 1995 ; Vol. 36, No. 6. pp. 935-938.
@article{6bb075db4e624109a9846893ca0d67a9,
title = "Characterisation of patients with a complete biochemical response to ursodeoxycholic acid",
abstract = "Ursodeoxycholic acid (UDCA) leads to biochemical and clinical improvement in many patients with primary biliary cirrhosis (PBC); although, the response is variable. This study compared UDCA treated patients with complete normalisation of biochemical functions to those without such improvement. Of the 65 patients receiving UDCA, 12 (19{\%}) showed normalisation of liver biochemical functions at two years. The remaining 53 patients showed a less complete response. Mean (SD) alkaline phosphatase and total serum bilirubin values were significantly lower at entry in the patients whose liver biochemistry tests normalised (912 (732) U/l v 1417 (1021) U/l, p = 0.003, and 0.7 (12.1 (5.2) μmol/l v 38.9 (48.5) μmol/l, p = 0.0002, respectively), and percentage of UDCA in biliary bile acid was higher (56.3 (9.5){\%} v 38.3 (21.1){\%}, p = 0.03). Patients with biochemically and histologically less severe disease, and greater enrichment of biliary bile with UDCA, are more likely to respond favourably to the drug. The main objective of continued study will be to find out if normal liver biochemical functions can retard disease progression. The association of greater UDCA enrichment with complete biochemical responses suggests that higher doses of UDCA should be evaluated.",
keywords = "Primary biliary cirrhosis, Ursodeoxycholic acid",
author = "Jorgensen, {R. A.} and Dickson, {E. R.} and Hofmann, {A. F.} and Rossi, {S. S.} and Keith Lindor",
year = "1995",
month = "6",
language = "English (US)",
volume = "36",
pages = "935--938",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Characterisation of patients with a complete biochemical response to ursodeoxycholic acid

AU - Jorgensen, R. A.

AU - Dickson, E. R.

AU - Hofmann, A. F.

AU - Rossi, S. S.

AU - Lindor, Keith

PY - 1995/6

Y1 - 1995/6

N2 - Ursodeoxycholic acid (UDCA) leads to biochemical and clinical improvement in many patients with primary biliary cirrhosis (PBC); although, the response is variable. This study compared UDCA treated patients with complete normalisation of biochemical functions to those without such improvement. Of the 65 patients receiving UDCA, 12 (19%) showed normalisation of liver biochemical functions at two years. The remaining 53 patients showed a less complete response. Mean (SD) alkaline phosphatase and total serum bilirubin values were significantly lower at entry in the patients whose liver biochemistry tests normalised (912 (732) U/l v 1417 (1021) U/l, p = 0.003, and 0.7 (12.1 (5.2) μmol/l v 38.9 (48.5) μmol/l, p = 0.0002, respectively), and percentage of UDCA in biliary bile acid was higher (56.3 (9.5)% v 38.3 (21.1)%, p = 0.03). Patients with biochemically and histologically less severe disease, and greater enrichment of biliary bile with UDCA, are more likely to respond favourably to the drug. The main objective of continued study will be to find out if normal liver biochemical functions can retard disease progression. The association of greater UDCA enrichment with complete biochemical responses suggests that higher doses of UDCA should be evaluated.

AB - Ursodeoxycholic acid (UDCA) leads to biochemical and clinical improvement in many patients with primary biliary cirrhosis (PBC); although, the response is variable. This study compared UDCA treated patients with complete normalisation of biochemical functions to those without such improvement. Of the 65 patients receiving UDCA, 12 (19%) showed normalisation of liver biochemical functions at two years. The remaining 53 patients showed a less complete response. Mean (SD) alkaline phosphatase and total serum bilirubin values were significantly lower at entry in the patients whose liver biochemistry tests normalised (912 (732) U/l v 1417 (1021) U/l, p = 0.003, and 0.7 (12.1 (5.2) μmol/l v 38.9 (48.5) μmol/l, p = 0.0002, respectively), and percentage of UDCA in biliary bile acid was higher (56.3 (9.5)% v 38.3 (21.1)%, p = 0.03). Patients with biochemically and histologically less severe disease, and greater enrichment of biliary bile with UDCA, are more likely to respond favourably to the drug. The main objective of continued study will be to find out if normal liver biochemical functions can retard disease progression. The association of greater UDCA enrichment with complete biochemical responses suggests that higher doses of UDCA should be evaluated.

KW - Primary biliary cirrhosis

KW - Ursodeoxycholic acid

UR - http://www.scopus.com/inward/record.url?scp=0029041723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029041723&partnerID=8YFLogxK

M3 - Article

C2 - 7615288

AN - SCOPUS:0029041723

VL - 36

SP - 935

EP - 938

JO - Gut

JF - Gut

SN - 0017-5749

IS - 6

ER -